October 15, 2020: COSMED introduces BOD POD GS-X, the 4th generation of the world’s first and only Air Displacement Plethysmograph (ADP), the Gold Standard for two compartment Body Composition model.

Posted on 02 November 2020, English, Company, Italiano, Deutsch, French

October 15, 2020: COSMED introduces BOD POD GS-X, the 4th generation of the world’s first and only Air Displacement Plethysmograph (ADP), the Gold Standard for two compartment Body Composition model.

COSMED introduces BOD POD GS-Xthe 4th generation of the world’s first and only Air Displacement Plethysmograph (ADP), the Gold Standard for two compartment Body Composition model.

COSMED, world-wide leader manufacturer of Cardiopulmonary, Metabolic and Body Composition diagnostic equipment for clinical and human performance applications, announced today the release of BOD POD GS-Xa new generation of Body Composition Tracking System for quick, safe and non-invasive Body Composition assessment in adults and children. 

February 16, 2020: COSMED acquires Innovision ApS Technology to expand presence in the Nordic market

Posted on 16 February 2020, English, Company, Italiano, Deutsch, French

February 16, 2020: COSMED acquires Innovision ApS Technology to expand presence in the Nordic market

COSMED Announces Acquisition of Innovision Technology to Expand Product Portfolio and Presence in the Nordic Markets.

COSMED headquartered in Rome, Italy, leading manufacturer of Metabolic and Body composition technologies, has acquired assets of Innovision ApS, a Danish Company with significant know-how and expertise in the design of products for Hemodynamic (Cardiac Output), Ventilation Heterogeneity (Lung Clearance Index) and Metabolic measurements (VO2Max).

February 13, 2020: COSMED announces U.S. FDA 510(K) clearance of Q-NRG+ and Q-NRG Indirect Calorimetry device.

Posted on 14 February 2020, English, Company, Italiano, Deutsch, French

February 13, 2020: COSMED announces U.S. FDA 510(K) clearance of Q-NRG+ and Q-NRG Indirect Calorimetry device.

COSMED is glad to announce the U.S. Food and Drug Administration (FDA) clearance of Q-NRG+ and Q-NRG, a metabolic monitoring device utilizing Indirect Calorimetry (IC) technology intended for the measurement of Resting Energy Expenditure (REE) in patients who are mechanically ventilated or spontaneously breathing.

Feb 10, 2020: COSMED commitment during the current COVID-19 global pandemic

Posted on 10 February 2020, English, Company, Italiano, Deutsch, French

Feb 10, 2020: COSMED commitment during the current COVID-19 global pandemic

During these exceptional times, we would like to inform you that COSMED is adapting to the COVID-19 situation with diligence and is trying to face this big challenge with determination.

We wanted to take a moment to share with our customers, partners and communities how COSMED is responding to this evolving situation.

COSMED introduces Q-NRG, the new metabolic monitor for energy expenditure measurements in mechanically ventilated and spontaneous breathing patients in ICU

Posted on 08 March 2018, English, Company, Italiano, Deutsch, French

indirect calorimetry

Rome (Italy) - March 2018 - COSMED, world-wide leader in the design of metabolic systems for clinical and human performance applications, announced today the release of a new product line of metabolic monitors for quick, accurate, intuitive and affordable indirect calorimetry.

[12 3 4  >>